Broadwood Capital Inc., 10% Owner at OncoCyte Corp (OCX), bought 1,066,666 shares at $3.75 ($4.0M) on 2019-02-08, disclosed to the SEC on 2019-02-12.
Open-market purchase of $4.0M OCX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 533,333 | $2.0M | 50.0% |
| 2 | $3.75 | 533,333 | $2.0M | 50.0% |
| Total | $3.75 avg | 1,066,666 | $4.0M | 100% |
| Filing → |
| STAA | BUY | 2025-03-20 | $7.2M | — | Filing → |
| STAA | BUY | 2025-03-06 | $964K | — | Filing → |
| STAA | BUY | 2025-03-03 | $22.5M | — | Filing → |